Kinetics of inhibition of HIV type 1 reverse transcriptase-bearing NRTI-associated mutations by apricitabine triphosphate. 2007

Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
McGill AIDS Centre, Lady Davis Institute-Jewish General Hospital, Montreal, Quebec, Canada.

We wished to investigate the effects of various mutations in HIV-1 reverse transcriptase (RT) on biochemical inhibition by the active form of a novel nucleoside termed apricitabine. Accordingly, we studied the efficiency of chain-termination mediated by apricitabine triphosphate (TP) in cell-free assays that used either recombinant wild-type or mutated RTs. We also performed steady-state-kinetics and primer-unblocking assays. Subtype C RTs were also analysed. The results showed that the K65R mutation in RT caused reductions in the efficiency of chain-termination of apricitabine-TP by increasing its Ki. However, K65R did not affect rates of primer unblocking for apricitabine-TP. No significant differences were found between subtype C and subtype B RTs with regard to any of the parameters studied. Other mutations such as M184V, L74V and K103N had no effect on the efficiency of chain termination by apricitabine-TP. Thus, the mechanism of reduced susceptibility to apricitabine of viruses containing K65R in RT seems to be mediated exclusively through a reduction in binding or incorporation of apricitabine-TP. Unlike some other nucleoside analogues, increased excision of incorporated apricitabine does not seem to be a cause of resistance to apricitabine.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
October 2009, The Annals of pharmacotherapy,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
March 1994, Biochemistry,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
January 2001, Nucleosides, nucleotides & nucleic acids,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
November 2021, Journal of medicinal chemistry,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
June 2006, Biochemistry,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
December 2009, The Journal of biological chemistry,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
September 1990, European journal of biochemistry,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
October 1994, AIDS research and human retroviruses,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
November 1993, Biochemistry,
Fernando A Frankel, and Dimitrios Coutsinos, and Hongtao Xu, and Mark A Wainberg
January 2022, Journal of medicinal chemistry,
Copied contents to your clipboard!